51 results
424B3
CTCX
Carmell Corp - Ordinary Shares
5 Jun 24
Prospectus supplement
6:06am
expressed substantial doubt about our ability to continue as a going concern.
We may become involved in litigation that may materially adversely affect … result in expensive arbitration, litigation or other dispute resolution, which may not be resolved in our favor and may adversely impact our financial
8-K
EX-10.1
CTCX
Carmell Corp - Ordinary Shares
4 Apr 24
Carmell Announces $3.0 Million Private Placement
5:28pm
of information.
(j)Litigation. Other than as set forth in the SEC Reports, there is no material Proceeding pending or, to the knowledge of the Company … to any damage or penalty in any criminal or governmental litigation or Proceeding under any provision of the FCPA.
(dd)Accountants. The Company’s
8-K
EX-10.1
g6raru6x
25 Mar 24
Entry into a Material Definitive Agreement
8:46pm
8-K
EX-99.1
k11mkvtwiv6
25 Mar 24
Entry into a Material Definitive Agreement
8:46pm
8-K
EX-10.1
47pwz dngv24
5 Jan 24
Departure of Directors or Certain Officers
4:39pm
NT 10-Q
bfhofibt16hceydi uea
15 Nov 23
Notice of late quarterly filing
4:56pm
8-K/A
EX-99.2
5up2i7f zad7no327x
25 Oct 23
Unaudited Condensed Financial Statements
4:02pm
8-K/A
EX-99.1
i1srm69qz8654nj0o2h
25 Oct 23
Unaudited Condensed Financial Statements
4:02pm
8-K
EX-10.1
qa2yvgrn
1 Aug 23
Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
4:39pm
8-K
3jt2 ma3sw94
20 Jul 23
Entry into a Material Definitive Agreement
5:21pm
425
cjdzpxv e0221vc3of
10 Jul 23
Business combination disclosure
8:03am
8-K
EX-10.2
xkork6f
10 Jul 23
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.1
b49tr6mqhxj71m6jd
10 Jul 23
Entry into a Material Definitive Agreement
8:00am